Introduction
The autoimmune inner ear disease (AIED) is a clinical syndrome with uncertain pathogenesis that is often associated to rapidly progressive hearing loss that, especially in the early stages of disease, may be at monoaural localization, although more often it is at binaural localization It usually occurs in the form of sudden deafness or a rapidly progressive sensorineural hearing loss. 1 Hearing loss in idiopathic form may be associated with vestibular disease. Autoimmune inner ear disease consists of a heterogeneous group of disorders that characterize the clinical presentation and immunologic reactivity of inner ear components.
The immune dysfunction of patients with AIED has been studied using the lymphocyte transformation tests, immunofluorescence techniques, Western blot and countless amount of antigen. Among these analyzes, the Western blot test is widely used to diagnose AIED and to set the therapeutic range suitable. 2 The immune system is a particularly complex system and it may cause damage in different ways to the various components of the inner ear. Many systemic diseases may be associated with Cogan's syndrome, such as: ankylosing spondylitis; systemic lupus erythematosus; Sjoegren's syndrome; ulcerative colitis; Wegener's granulomatosis; rheumatoid arthritis; scleroderma; psoriatic arthritis. 3 Humoral and cell-mediated mechanisms are involved in the pathogenesis of autoimmune inner ear disease. Cochlear innate immunity has been proposed to contribute to the initiation of a local adaptive immune response following antigen challenge. Briefly, as a consequence of a yet undefined trigger damaging the inner ear, lymphocytes from the systemic circulation are exposed to proteins of the cochlea.
Immune cells pass from the systemic circulation, through the blood-labyrinthine barrier, to reach the endolymphatic sac. Specifically, the vessels of the spiral modiolar vein, adjacent to the scala tympani, appears to be the initial entry site of lymphocyte cells in the inner ear. Chronic activation of helper T lymphocytes reactive against self-proteins leads to the destruction of sensory and supporting cells within the cochlea. IL-1α, IL-2, TNF-α and NF-κB, cytokines essential in the initiation, modulation and amplification of the immune response, are expressed by infiltrating cells in the endolymphatic sac. 4 Many studies in animal models have led to the hypothesis that in the pathogenesis of autoimmune hearing loss you can achieve a cytotoxic antibody-mediated damage (type II response) or immune complex-mediated damage (type III response). In the serum of approximately 70% of patients with sudden sensorineural hearing Loss (SSHL) of unknown aetiology, it is possible to find antibodies capable of immunostaining human inner ear tissues. Autoantibodies against type II collagen, type IX collagen, Raf-1 protein, the major peripheral myelin protein P0, B-actin, cochlin, choline transporter-like protein 2 (CTL2), cell-density enhanced protein tyrosine phosphatase-1 and connexin 26 have all been described in AIED. The stria vascularis, fibrocytes of the spiral ligament and supporting cells are the anatomical targets of those autoantibodies. 5 Sometimes in pathogenic dynamics of such forms it is possible to detect a common denominator with diseases from autoimmune disorder and pathological conditions involving cellular oxidative stress. [6] [7] [8] [9] [10] [11] In this context, a particular form of autoimmune inner ear disease is represented by Cogan's syndrome (CS). 12 Cogan's syndrome is a chronic inflammatory disorder that most commonly affects young adults. Clinical hallmarks are interstitial keratitis, vestibular and auditory dysfunction. Associations between CS and systemic vasculitis, as well as aortitis, also exist. 13 The mechanisms responsible for the eye and inner ear disease in Cogan's syndrome are unknown. Some evidence suggests that the disease is a result of inner ear autoimmunity. A few patients display reactivity against antigens expressed in the inner ear. These antigens share sequence homology with Ro/SSA autoantigen, laminin, cell density-enhanced protein tyrosine-1 (DEP-1/CD148), connexin 26, and the reovirus III major core protein lambda1. 14 In animals, passive transfer of the autoantibodies reproduced features of CS in mice; this supports a hypothesis that infection, perhaps from reovirus type III, may be involved in triggering this autoimmune disease through molecular mimicry. This is further supported by the observations that one-quarter to one-third of patients with CS have an antecedent viral-like illness. 15, 16 In addition, antibodies to Hsp-70 have been detected in some patients with CS and other forms of autoimmune sensorineural hearing loss.
Case Report
The female patient, aged 25, has come to our attention to the sudden appearance of monaural hearing loss, in the right ear, and dizzying acute syndrome two days before.
The anamnestic survey also revealed the presence of right ear tinnitus, started with hearing loss, in conjunction with febrile episodes (~39°C) and visual disturbances, which instead were insurgents about a month before and for which diagnosis was made of conjunctivitis.
The vestibular examination showed the reduction of the right labyrinthine function: Videooculoscopy: presence of spontaneous, second-degree, horizontal nystagmus, with fast phase directed to
The audiological evaluation showed: Tonal audiometric examination: presence of sensorineural hearing loss in right ear, mainly for medium and high frequencies. Normal hearing in left ear ( Figure 1) ; Impedenzometric examination: tympanogram type A bilaterally and positivity of Metz's test in right ear, indicative of cochlear suffering; ABR examination: deconstructed track, using 120 dB SPL click stimulus, in right ear; normal track, with regular attendance of the waves, in left ear.
At that stage it was placed diagnosis of sudden hearing loss with vestibular impairment in right ear.
They were administered vasoactive and neurotrophic drugs for ten days. At the follow up, after ten days, was highlighted the disappearance of the vertiginous state, persistent moderate imbalance, and an improvement of auditory function in right ear (Figure 2) .
The patient was advised to continue vasoactive and neurotrophic therapy for further seven days. The patient after 7 days to follow up reported a further deterioration of hearing loss in right ear, with the average loss values greater than those of the initial event. The patient also reported a subjective feeling of frequent changes in hearing sensitivity, independent of ponderable factors. A condition of imbalance persisted, without vertiginous state.
The diagnostic evaluation therefore provided viral titrations for Herpes simplex virus, Cytomegalovirus, Herpes Zoster virus, Syphilis and Lyme disease. These tests were negative for infection either past or present.
Cerebral magnetic resonance (high-resolution) imaging showed normal MRI findings.
It has been advanced the hypothesis of a condition of hydrops endolymphatic, which is why then administered depletional therapy and recommended a low-salt diet. After twenty days, at new follow-up, stationary hearing condition and phenomena of disequilibrium were found. Then were carried out a new eye examination and blood tests, aimed at the study of the immune profile.
The eye examination revealed the presence of keratitis in both eyes, while a significant increase was highlighted in blood chem- istry tests of white blood count, erythrocyte sedimentation rate and CRP. The values of complement C3 and C4 and radial immunodiffusion were out of norm and there was positivity of the anti-Hsp70 antibody test. On the basis of the findings it was assumed typical Cogan's syndrome, which is why the patient was started at Division of Clinical Immunology where she began intravenously corticosteroid therapy in high doses for ten days and then continued with oral steroid therapy, at low doses, in combination with methotrexate, cyclophosphamide, cyclosporine, folin, acetylsalicylic acid.
The patient is then subjected to control after 40 days, and then after 2 months.
The first and second follow up showed no particular changes on the side of audiology, although extrauditive manifestations were improved.
Discussion
The present study describes the clinical evolution and longterm follow-up of patient suffering from Cogan's syndrome.
Cogan's syndrome is a rare autoimmune vasculitis, and its pathogenesis is unknown. Infection, but primarily autoimmunity, may play contributing roles in the pathogenesis of this disease. It is characterized by ocular and audiovestibular symptoms similar to those of Meniere's syndrome. Approximately 70% of patients have systemic disease, of which vasculitis is considered the pathological mechanism. The immunologic theory is based on the release of auto-antibodies against corneal, inner ear and endothelial antigens, and of anti-nuclear cytoplasmic auto-antibodies (ANCA). 17 The etiology and mechanism of Cogan's syndrome remain unknown. Exposure to a toxic substance preceded symptom onset in several patients but it was primarily the possible triggering role of an infection, present in 30% of the cases in the weeks preceding ocular or audiovestibular symptomatology, that is evoked.
In our patient, elevated white blood count, erythrocyte sedimentation rate and CRP as well as some non-specific alterations of the complement system, positivity of the anti-Hsp70 antibody test were the only notable abnormal laboratory parameters. These findings, often noticed in inflammatory processes, however, are nonspecific. Only when cardinal symptoms, cochleovestibular and eye disease, are present does the clinical diagnosis of Cogan's syndrome becomes obvious. The diagnostic mainstay is to verify the presence of interstitial keratitis.
Cogan's syndrome should always be considered in patients presenting a progressive hearing loss associated with ocular inflammations. According to the findings of this study, early recognition of Cogan's syndrome and rapid initiation of combined immunosuppressive therapy, such as corticosteroids and cyclophosphamide, seem to be important in preventing persistent deafness. Whether systemic complications and a fatal outcome also can be prevented still remains unanswered.
Conclusions
The nosology of Cogan's syndrome remains poorly defined. The boundaries between this disease and immunological deafness or systemic diseases affecting the eye and ear remain to be established. The etiology and mechanisms of Cogan's syndrome are unknown: the role of triggering factors -perhaps infectious -has been evoked, as have immunological reactions directed against constituents of the eye and/or inner ear. The succession of symptoms described in the case reported in the present study raises early stage of considerable diagnostic doubts. Few aspects of the case in question in fact differ from similar events to sudden hearing loss, as vestibular neuronitis, as Meniere's disease.
Unique different element was the fever, even if such a symptom not typifies the disease in question.
It is important in such cases that, in relation also to the young age, is suspected an immune disorder, type of Cogan's syndrome, so that the establishment of appropriate therapy can control the clinical evolution
No biological test is available at present to affirm the diagnosis of the disease.
Treatment is poorly codified: the modalities of cortico-therapy and recourse to other therapeutic agents, notably immune-suppressants, in the case of cortico-resistance or cortico-dependence merit new studies.
